Abstract
Background: Anti-JCV antibody testing has been increasingly used to stratify MS patients into different disease modifying therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.msard.2018.10.048
Publication Date: Nov 1, 2018 |
Background: Anti-JCV antibody testing has been increasingly used to stratify MS patients into different disease modifying therapies.
Join us for a 30 min session where you can share your feedback and ask us any queries you have